1. Home
  2. ELEV vs DUOT Comparison

ELEV vs DUOT Comparison

Compare ELEV & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • DUOT
  • Stock Information
  • Founded
  • ELEV 2019
  • DUOT 1990
  • Country
  • ELEV United States
  • DUOT United States
  • Employees
  • ELEV N/A
  • DUOT N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • ELEV Health Care
  • DUOT Technology
  • Exchange
  • ELEV Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • ELEV 34.0M
  • DUOT 34.8M
  • IPO Year
  • ELEV 2021
  • DUOT N/A
  • Fundamental
  • Price
  • ELEV $0.61
  • DUOT $4.89
  • Analyst Decision
  • ELEV Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • ELEV 5
  • DUOT 1
  • Target Price
  • ELEV $7.80
  • DUOT $6.00
  • AVG Volume (30 Days)
  • ELEV 673.9K
  • DUOT 69.6K
  • Earning Date
  • ELEV 11-06-2024
  • DUOT 11-19-2024
  • Dividend Yield
  • ELEV N/A
  • DUOT N/A
  • EPS Growth
  • ELEV N/A
  • DUOT N/A
  • EPS
  • ELEV N/A
  • DUOT N/A
  • Revenue
  • ELEV N/A
  • DUOT $7,346,014.00
  • Revenue This Year
  • ELEV N/A
  • DUOT $66.43
  • Revenue Next Year
  • ELEV N/A
  • DUOT $83.75
  • P/E Ratio
  • ELEV N/A
  • DUOT N/A
  • Revenue Growth
  • ELEV N/A
  • DUOT N/A
  • 52 Week Low
  • ELEV $0.44
  • DUOT $1.94
  • 52 Week High
  • ELEV $5.83
  • DUOT $6.44
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 51.53
  • DUOT 59.40
  • Support Level
  • ELEV $0.52
  • DUOT $4.08
  • Resistance Level
  • ELEV $0.70
  • DUOT $6.44
  • Average True Range (ATR)
  • ELEV 0.06
  • DUOT 0.48
  • MACD
  • ELEV 0.00
  • DUOT -0.01
  • Stochastic Oscillator
  • ELEV 41.81
  • DUOT 43.22

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: